Medical AI

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

An award-winning technology is transforming how hospitals treat a deadly diabetic complication in children, minimizing errors and improving patient safety.

With a new $17.5M financing, Forlong Biotechnology accelerates its promising IL-15 and IL-18 cancer drugs, aiming to redefine post-PD-1 immunotherapy.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

A new study reveals 93% of clinical photos from smartphones are unreliable, risking misdiagnosis. Discover the tech bringing accuracy back to medicine.

Medtech innovator FastWave Medical secures key patents in Australia and Japan, escalating the battle for the multi-billion-dollar artery treatment market.

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

A Santa Barbara senior community's immersive 'Star Room' wins a top award, signaling a major shift in technology-driven dementia care and well-being.

A senior living provider is expanding a real-time tracking system after it cut overnight falls by 50%, heralding a new era of proactive, data-driven elder care.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

A new partnership between Hong Kong's PAIR and the UK's Cambridge NeuroWorks aims to accelerate brain health innovations through a global seminar series.

Industry veteran Steve Motes joins Tulyp Medical as CEO, aiming to commercialize a revolutionary pressure-driven perfusion system with a proven team.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

A startup's radical new model, born from a family's health crisis, directs all pediatric revenue to fund rare disease research and support families.

A record-breaking medical conference reveals a major shift in medicine, as practitioners move from simply managing aging to pursuing biological age reversal.

A new bispecific antibody, EPI-326, enters human trials, hoping its unique tissue-selective degradation can defeat EGFR-driven cancers where others fail.

New data shows Imofinostat turns 'cold' colorectal tumors 'hot' for immunotherapy and breaks chemo-resistance in pancreatic cancer, fueling pivotal trials.

A new clinical trial is underway for a next-gen aortic valve, promising a less invasive procedure and improved durability for millions of patients.

FDA clears Allevion's Vantage™, a disposable kit with integrated visualization that targets bone growth, aiming to transform spinal decompression.